| 名稱 | LNCAP-Luc示蹤細(xì)胞株 |
| 型號(hào) | CBP30195L |
| 報(bào)價(jià) |  |
| 特點(diǎn) | LNCAP-Luc示蹤細(xì)胞株，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 科學(xué)家如何深度破解癌癥基因組的奧秘？
- 泛腫瘤大panel質(zhì)控品升級(jí)，免費(fèi)試用申請(qǐng)中
- 有關(guān)細(xì)胞株生長(zhǎng)要考慮的因素
- A2A受體家族細(xì)胞篩選模型
- 腫瘤免疫新型靶點(diǎn)——趨化因子受體
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- ATCC細(xì)胞株的特殊性質(zhì)或標(biāo)志必須在整個(gè)培養(yǎng)期間始終存在
- 降糖+減肥？GIPR靶點(diǎn)研究進(jìn)展
- 4-1BB（CD137）靶點(diǎn)藥物篩選模型
- 細(xì)胞株開發(fā)的主要過程要知道
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
- 詳細(xì)內(nèi)容
LNCAP-Luc示蹤細(xì)胞株 CBP30195L | |
| I. Introduction | |
| Host Cell: | LNCAP (AR positive, p.T868A) |
| Expressed gene: | Luciferase |
| Stability: | 32 passages(in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+15%FBS+1ug/ml puromycin |
| Mycoplasma Status: | Negative |
| Storage: | Liquid nitrogen |
| II. Description of Host Cell Line | |
| Organism: | Homo sapiens, human |
| Tissue: | Prostate |
| Disease: | Prostate carcinoma |
| Morphology: | Adherent fibroblastoid cells growing in aggregates and as single cells |
| Growth Properties: | Mixed adherentsuspension |
| III. Representative Data | |
| |
Figure. Detect Luciferase assay by Promega Bright-Glo Luciferase Assay System. The number of Luminescence signal is 445±18(Mean±SD) on LNCAP cells while 104579±1558(Mean±SD) on LNCAP-Luc cells. | |
| IV. Stablity Test | |
| |
Figure.Stablity test results. LNCAP-Luc cells showed at least 32 passage stability with similar luminescence unit. | |
會(huì)員_a.png)